These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23084548)

  • 1. Heme oxygenase-1: an important therapeutic target for protecting against myocardial ischemia and reperfusion injury.
    Hu X; Wang J; Jiang H
    Int J Cardiol; 2013 Jul; 167(2):587-8. PubMed ID: 23084548
    [No Abstract]   [Full Text] [Related]  

  • 2. Upregulation of heme oxygenase-1 expression for protecting against myocardial ischemia and reperfusion injury.
    Zhang X; Liu W; Jian Y; Zhang Y; Bian C; Liu S
    Int J Cardiol; 2013 Sep; 167(6):3027-8. PubMed ID: 23199553
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cardioprotective effect of heme oxygenase-1 induction by hemin on the isolated rat heart during ischemia--reperfusion].
    Kukoba TV; Moĭbenko OO; Kotsioruba AV
    Fiziol Zh (1994); 2003; 49(6):14-21. PubMed ID: 14965033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-methoxycinnamaldehyde from Cinnamomum cassia reduces rat myocardial ischemia and reperfusion injury in vivo due to HO-1 induction.
    Hwa JS; Jin YC; Lee YS; Ko YS; Kim YM; Shi LY; Kim HJ; Lee JH; Ngoc TM; Bae KH; Kim YS; Chang KC
    J Ethnopharmacol; 2012 Jan; 139(2):605-15. PubMed ID: 22179023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activating transcription factor 3: A promising therapeutic target for remission myocardial ischemia reperfusion injury.
    Yang CJ; Fan ZX; Yang J; Yang J
    Int J Cardiol; 2015 Dec; 201():102-3. PubMed ID: 26292276
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction of heme oxygenase-1 can act protectively against cardiac ischemia/reperfusion in vivo.
    Hangaishi M; Ishizaka N; Aizawa T; Kurihara Y; Taguchi J; Nagai R; Kimura S; Ohno M
    Biochem Biophys Res Commun; 2000 Dec; 279(2):582-8. PubMed ID: 11118329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heme oxygenase-1 protects the heart.
    Choi AM
    Circ Res; 2001 Jul; 89(2):105-7. PubMed ID: 11463713
    [No Abstract]   [Full Text] [Related]  

  • 8. The Nrf-2/ARE-HO-1 axis: An important therapeutic approach for attenuating myocardial ischemia and reperfusion injury-induced cardiac remodeling.
    Wang J; Hu X; Jiang H
    Int J Cardiol; 2015 Apr; 184():263-264. PubMed ID: 25726904
    [No Abstract]   [Full Text] [Related]  

  • 9. HDAC inhibition: A novel therapeutic target for attenuating myocardial ischemia and reperfusion injury by reversing cardiac remodeling.
    Wang J; Hu X; Jiang H
    Int J Cardiol; 2015; 190():126-7. PubMed ID: 25918063
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardioprotection by epsilon-protein kinase C activation from ischemia: continuous delivery and antiarrhythmic effect of an epsilon-protein kinase C-activating peptide.
    Inagaki K; Begley R; Ikeno F; Mochly-Rosen D
    Circulation; 2005 Jan; 111(1):44-50. PubMed ID: 15611364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat Model.
    Nagaoka K; Matoba T; Mao Y; Nakano Y; Ikeda G; Egusa S; Tokutome M; Nagahama R; Nakano K; Sunagawa K; Egashira K
    PLoS One; 2015; 10(7):e0132451. PubMed ID: 26167913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MSCs modified with HO-1 gene transplantation: a novel therapeutic approach for attenuating myocardial ischemia and reperfusion injury.
    Wang J; Hu X; Jiang H
    Int J Cardiol; 2015 Feb; 180():38-9. PubMed ID: 25438204
    [No Abstract]   [Full Text] [Related]  

  • 13. Intracoronary levosimendan prevents myocardial ischemic damages and activates survival signaling through ATP-sensitive potassium channel and nitric oxide.
    Caimmi PP; Molinari C; Uberti F; Micalizzi E; Valente G; Mary DA; Vacca G; Grossini E
    Eur J Cardiothorac Surg; 2011 Apr; 39(4):e59-67. PubMed ID: 21247774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipase C as a potential target for cardioprotection during oxidative stress.
    Tappia PS; Asemu G; Rodriguez-Leyva D
    Can J Physiol Pharmacol; 2010 Mar; 88(3):249-63. PubMed ID: 20393590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cardioprotective effect of sodium tanshinone IIA sulfonate and the optimizing of therapeutic time window in myocardial ischemia/reperfusion injury in rats.
    Wei B; Li WW; Ji J; Hu QH; Ji H
    Atherosclerosis; 2014 Aug; 235(2):318-27. PubMed ID: 24911635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial overview: cardioprotective drugs for myocardial ischemic injury--a therapeutic area at risk.
    Knight DR
    Curr Opin Investig Drugs; 2007 Mar; 8(3):190-2. PubMed ID: 17408113
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral administration of Lactobacillus induces cardioprotection.
    Oxman T; Shapira M; Klein R; Avazov N; Rabinowitz B
    J Altern Complement Med; 2001 Aug; 7(4):345-54. PubMed ID: 11558777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischemic preconditioning involves phospholipase D.
    Trifan OC; Popescu LM; Tosaki A; Cordis G; Das DK
    Ann N Y Acad Sci; 1996 Sep; 793():485-8. PubMed ID: 8906197
    [No Abstract]   [Full Text] [Related]  

  • 19. Myocardial postconditioning: next step to cardioprotection.
    Rohilla A; Rohilla S; Kushnoor A
    Arch Pharm Res; 2011 Sep; 34(9):1409-15. PubMed ID: 21975801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic and functional protection by selective inhibition of nitric oxide synthase 2 during ischemia-reperfusion in isolated perfused hearts.
    Ramasamy R; Hwang YC; Liu Y; Son NH; Ma N; Parkinson J; Sciacca R; Albala A; Edwards N; Szabolcs MJ; Cannon PJ
    Circulation; 2004 Apr; 109(13):1668-73. PubMed ID: 15051645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.